The 20 Best Lynch Syndrome Doctors Near Me in Ann Arbor, MI

Imad Shureiqi is an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Shureiqi is rated as a Distinguished provider by MediFind in the treatment of Lynch Syndrome. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Pseudomyxoma Peritonei. Dr. Shureiqi is board certified in Medical Oncology.

John C. Byrn, M.D is a Clinical Professor of Surgery in the Division of Colorectal Surgery. He graduated from Hope College with a B.A. in Chemistry and received his MD degree from the University of Illinois-Chicago College of Medicine. He trained in general surgery at Mount Sinai School of Medicine in New York, NY. Dr. Byrn went on for his Colon and Rectal residency at the Cleveland Clinic, Cleveland, OH. Dr. Byrn was a Clinical Assistant and Associate Professor of Surgery at the University of Iowa Hospitals and Clinics from 2009-2015 and served as the Chief of the Section of Colorectal Surgery from 2013-2105. Dr. Byrn is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Rectal Prolapse, Familial Colorectal Cancer, Ileostomy, and Colostomy. Dr. Byrn is board certified in Surgery and Colon & Rectal Surgery.

Dr. Michael McGee is Clinical Associate Professor of Surgery and Chief of the Division of Colorectal Surgery at the University of Michigan. Prior to obtaining his medical degree at Drexel University, he was trained as a mechanical engineer. After completing general surgery training at Case Western Reserve University, Dr. McGee completed colorectal surgery fellowship at Cleveland Clinic. While at Case Western, Dr. McGee completed the Dudley P. Allen Scholarship dedicated to clinical research in minimally invasive surgery and surgical endoscopy. Dr. McGee was recruited to Northwestern University where he practiced for 11 years and held several system-wide administrative roles for Northwestern Medicine before joining the University of Michigan in 2022. Dr. McGee’s clinical interests include complex re-operative abdominal surgery, minimally invasive colorectal surgery, surgical endoscopy, and anorectal surgery for cancer and inflammatory bowel disease. He served as co-director of the 50+ hospital Illinois Surgical Quality Improvement Collaborative (ISQIC) where he led day-to-day operations and statewide quality improvement projects for thousands of surgical patients in Illinois. Dr. McGee’s research interests include surgical quality improvement, implementation science, and patient education. He is an active member of several national surgical organizations, multiple editorial boards, and has authored over fifty publications and received multiple grants and awards for research, teaching, and humanism. Dr. Mcgee is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. He is also highly rated in 18 other conditions, according to our data. His clinical expertise encompasses Anal Cancer, Familial Colorectal Cancer, Gastrointestinal Fistula, Colostomy, and Hernia Surgery. Dr. Mcgee is board certified in Surgery and Colon & Rectal Surgery.

Scott Regenbogen, MD, MPH is a Professor of Surgery and Division Chief of Colorectal Surgery. He graduated from Princeton University with an A.B. in psychology, and received his M.D. degree from the University of California, San Francisco. He completed General Surgery residency at the Massachusetts General Hospital, including three years as a Postdoctoral Fellow in Health Services Research, and was awarded a Master’s in Public Health from the Harvard School of Public Health. He then completed fellowship training in Colon and Rectal Surgery at the Lahey Clinic, and joined the faculty of the University of Michigan in 2011.Clinical SpecializationDr. Regenbogen's clinical practice includes the evaluation and management of benign and neoplastic diseases of the small bowel, colon, rectum, and anus. He has a particular interest in the use of laparoscopic techniques for the management of colorectal cancer, diverticular disease and inflammatory bowel disease. Dr. Regenbogen is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Anal Cancer, Ileostomy, and Hernia Surgery. Dr. Regenbogen is board certified in Surgery and Colon & Rectal Surgery.

Samantha Hendren is a General Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Hendren is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Anal Cancer, Ileostomy, and Colostomy.

Calista Harbaugh, M.D. M.Sc. is a faculty member in the Division of Colorectal Surgery. Dr. Harbaugh graduated Summa Cum Laude with a B.S.E. in Biomedical Engineering from the University of Michigan in Ann Arbor, Michigan. She went on to receive her medical degree from the University of Michigan School of Medicine with Alpha Omega Alpha honors. She then completed her internship and residency in General Surgery at the University of Michigan, including 2 years as a Clinician Scholar in the National Clinician Scholars Program at the University of Michigan where she earned her Master’s degree in Health and Healthcare Research. She completed the Colon & Rectal Surgery Fellowship at the University of Minnesota, and returned to the University of Michigan as an Assistant Professor of Surgery.Clinical Specialization: Dr. Harbaugh’s clinical practice includes the evaluation and management of benign and neoplastic diseases of the small bowel, colon, rectum, and anus. She has a particular interest in the use of laparoscopic and robotic techniques for the management of colorectal cancer, diverticular disease and inflammatory bowel disease. Dr. Harbaugh is rated as an Experienced provider by MediFind in the treatment of Lynch Syndrome. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Rectal Prolapse, Familial Colorectal Cancer, Colorectal Cancer, Hemorrhoidectomy, and Ureteroscopy. Dr. Harbaugh is board certified in Surgery and Colon & Rectal Surgery.

Robert Cleary is a Colorectal Surgeon practicing medicine in Ypsilanti, Michigan. Dr. Cleary is rated as a Distinguished provider by MediFind in the treatment of Lynch Syndrome. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Diverticular Disease, Colostomy, and Ileostomy.

Dr. Veenstra earned her medical degree from Wayne State University in Detroit, Michigan and completed Internal Medicine internship and residency at the University of Michigan, where she also served as Chief Medical Resident. She completed her Medical Oncology fellowship training at the University of Pennsylvania, during which time she also earned a Masters in Health Policy Research. She joined the faculty at the University of Michigan in 2013.Dr. Veenstra’s research program focuses on the financial impacts of cancer diagnosis and treatment on patients and their families, the role of family in receipt of optimal cancer care, and issues facing cancer survivors. She currently holds a K07 Award from the National Cancer Institute to study the role of an engaged spouse or significant other in receipt of high quality surveillance care among survivors of colorectal cancer. Dr. Veenstra is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Gastroesophageal Junction Cancer. Dr. Veenstra is board certified in Medical Oncology.

I ride both a road bike and Peleton. I golf about 2-3 times per week. Have four grandchildren to dote on. I mostly fiction novels. Exercise twice per week. Dr. Terebelo is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. He is also highly rated in 62 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Essential Thrombocythemia, Familial Colorectal Cancer, Bone Marrow Aspiration, and Tissue Biopsy.

Grace Chen is a Hematologist and an Oncologist practicing medicine in Ann Arbor, Michigan. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Gastroesophageal Junction Cancer, Colorectal Cancer, and Neuroendocrine Tumor. Dr. Chen is board certified in Medical Oncology and Internal Medicine.

Oxana Crysler is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Crysler is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Familial Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Cholangiocarcinoma (Bile Duct Cancer). Dr. Crysler is board certified in Medical Oncology.

Dr. Zalupski is an Professor of Medicine in the division of Medical Oncology at the UMMC. He completed medical school, an internal medicine residency and a medical oncology fellowship at Wayne State University in Detroit. Dr. Zalupski's clinical and research interest is in experimental therapeutics of gastrointestinal malignancies and sarcomas. He also serves as the medical director of the Multidisciplinary Pancreatic Cancer Clinic. Dr. Zalupski is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Neuroendocrine Tumor, Familial Pancreatic Cancer, and Pancreaticoduodenectomy. Dr. Zalupski is board certified in Internal Medicine and Medical Oncology.

Thomas Enzler, MD PhD, is an Assistant Professor in the Division of Hematology and Oncology. He received his Master of Science from ETH Zurich and his Medical Degree from University of Basel, Switzerland. After completion of residency in Internal Medicine at University Hospitals of Zurich and Basel, Dr. Enzler did a research fellowship at the Dana Farber Cancer Institute, Harvard Medical School, Boston. There, he worked on projects focusing on tumor immune surveillance and his work resulted in several publications and in a PhD ‘magna cum laude’ in Biochemistry/Immunology (Harvard Medical School Boston/Max Delbrueck Center Berlin). He then moved to University of California San Diego to study signaling pathways of cancer cells and immune cells. While there, he successfully obtained ECFMG certification prior to doing clinic and laboratory research at Stanford University. From California Dr. Enzler went to Germany to do a Hematology and Oncology fellowship at University of Goettingen and he received board certification in both in Germany and in Switzerland. Dr. Enzler decided to return to the U.S. and completed U.S. residency in Internal Medicine at University of Arizona in Tucson. Following U.S. residency training, Dr. Enzler completed fellowship in Hematology and Oncology at Columbia University Medical Center, New York, where he worked on several research projects on gastrointestinal cancers. Dr. Enzler is rated as an Advanced provider by MediFind in the treatment of Lynch Syndrome. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Familial Pancreatic Cancer, and Pancreatic Ductal Adenocarcinoma. Dr. Enzler is board certified in Internal Medicine, Medical Oncology, and Hematology.

Versha Pleasant, MD, MPH, is a Clinical Assistant Professor in the Department of Obstetrics and Gynecology at the University of Michigan. She is also the Director of the Cancer Genetics and Breast Health Clinic at Von Voigtlander Women’s Hospital. She completed a Master of Public Health at Yale University and medical school training at Georgetown University School of Medicine. She then completed residency in Obstetrics and Gynecology, followed by a fellowship training in Cancer Genetics & Breast Health at the University of Michigan.Currently, Dr. Pleasant runs the Cancer Genetics & Breast Health Clinic, which cares for hundreds of patients with BRCA and other genetic mutations that increase the risk of breast and ovarian cancer. She also provides specialized gynecologic care for breast cancer survivors. She offers both medical care and surgical intervention for these patients, as well as the most cutting-edge and up-to-date information in the rapidly evolving field of cancer genetics.Dr. Pleasant is deeply interested in health disparities, particularly in breast cancer and genetic testing barriers facing Black women. She is currently co-investigator of a T32 NIH grant examining ways to increase education of genetic counseling and testing among African American women. She has previously served on the AAMC’s Group on Diversity and Inclusion, working on ways to decrease health disparities in medicine on a national level. She is also interested in novel ways to increase knowledge of healthcare providers in regards to genetic mutations that increase patients’ risk of breast and ovarian cancer. She has won multiple teaching awards during her training, namely the Golden Beeper Award, the Bronze Beeper Award, the Outstanding Educator Award, and the Token of Appreciation from Medical Students Award. She is also a member of the Gold Humanism Honor Society.Of note, prior to her career in medicine, Dr. Pleasant previously worked for several years as a Program Manager for the Centers for Disease Control and Prevention (CDC) in Sub-Saharan Africa (particularly Rwanda and Cote d’Ivoire). She is fluent in French. Dr. Pleasant is rated as an Experienced provider by MediFind in the treatment of Lynch Syndrome. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, Li-Fraumeni Syndrome, DICER1 Syndrome, and Intrauterine Device Insertion. Dr. Pleasant is board certified in Obstetrics & Gynecology.

Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is rated as an Experienced provider by MediFind in the treatment of Lynch Syndrome. She is also highly rated in 36 other conditions, according to our data. Her clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Vaishampayan is board certified in Medical Oncology.

Ibrahim Halil Sahin, MD, is medical oncologist specializing in gastrointestinal oncology. He is extensively involved in clinical trial development for colorectal cancer and nationally recognized expert in colorectal cancer. Dr. Sahin’s clinical and research interests focus on colorectal designing clinical trials with immunotherapy and targeted therapy for patients with advanced stage colorectal cancer. He is an active member of NCI Colon Task Force and Alliance Gastrointestinal Cancer and Colorectal Cancer Committees. He also currently serves as co-chair of HCRN Gastrointestinal Clinical Trial Working Group. Board-certified in medical oncology and internal medicine, he received his medical degree from Hacettepe University School of Medicine in Ankara, Turkey.Dr. Sahin completed two years of postdoctoral fellowship in Gastrointestinal Oncology Department/Experimental Therapeutics Department at MD Anderson Cancer Center, and an internal medicine residency at Icahn School of Medicine at Mount Sinai. He completed a hematology/oncology fellowship at Emory University School of Medicine, during which he received the ASCO Conquer Cancer Merit Award and Rochfort scholarship. In addition, Dr. Sahin was selected to participate in the AACR/ASCO Methods in Clinical Research Workshop in 2019. His focus of research in colorectal cancer is precision medicine and immunotherapeutics and he has been actively involved in drug development in this space. Dr. Sahin is rated as an Experienced provider by MediFind in the treatment of Lynch Syndrome. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Pancreatic Cancer, Familial Colorectal Cancer, and Familial Pancreatic Cancer.

Dr. Lawrence structured his career to prepare to be a physician scientist by obtaining both an MD and PhD. He initially pursued internal medicine and medical oncology, but ultimately settled on radiation oncology. He is board certified in all 3 areas. He has had an active clinical practice in radiation oncology for 30 years specializing in the treatment of patients with gastrointestinal malignancies and CNS tumors.Dr. Lawrence has focused his research career in two main areas. First, in collaboration with basic scientists he developed a laboratory program in chemotherapeutic radiation sensitizers and, more recently, has studied how to integrate molecularly targeted therapies. He collaborates with basic science faculty interested in translational research to investigate new combinations that can form the basis for rational clinical trials. The second area of focus involves the use of highly conformal radiation therapy in the treatment of brain and gastrointestinal cancers. In particular, he is focusing, in collaboration with medical physicists, radiologists, imaging scientists, and biologists, on the concept of adapting treatment to the individual patient response, assessed both by state-of-the-art imaging and plasma biomarkers.Dr. Lawrence is the author of over 300 peer-reviewed publications, and his work has been continuously supported by the National Cancer Institute for over 20 years. Dr. Lawrence is rated as an Experienced provider by MediFind in the treatment of Lynch Syndrome. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Glioma, Glioblastoma, Astrocytoma, Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Lawrence is board certified in Radiation Oncology, Medical Oncology, and Internal Medicine.

Paul Swiecicki is an Oncologist and an Internal Medicine provider practicing medicine in Ann Arbor, Michigan. Dr. Swiecicki is rated as an Experienced provider by MediFind in the treatment of Lynch Syndrome. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Oral Squamous Cell Carcinoma. Dr. Swiecicki is board certified in Medical Oncology.

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is rated as an Experienced provider by MediFind in the treatment of Lynch Syndrome. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.

Dr. Erin Cobain is a medical oncologist specializing in the care of patients with breast cancer and inherited cancer predisposition. She serves at Co-Director of the Breast Cancer Clinical Research Team at the Rogel Cancer Center. Dr. Cobain has been on faculty at the University of Michigan since 2016, when she completed her fellowship training. Dr. Cobain specializes in the care of patients with all types of breast cancer and those individuals who are at high risk of developing breast cancer. Dr. Cobain’s research interests include understanding how genetic and genomic testing can be utilized to personalize breast cancer therapy and use of immunotherapy treatments in breast cancer. Dr. Cobain serves as the Principal Investigator of a National Cancer Institute sponsored clinical trial exploring the role of combination chemotherapy and immunotherapy treatment in patients with hormone receptor positive, HER2 negative early-stage breast cancer with high genomic risk. Dr. Cobain is rated as an Experienced provider by MediFind in the treatment of Lynch Syndrome. She is also highly rated in 9 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast.